Company Filing History:
1 out of 815 
1 out of 49 
1 out of 136 
Years Active: 2016
Title: Innovator Masanori Fukushima: Pioneering Sustainable Drug Release
Introduction: Masanori Fukushima, a notable inventor based in Kyoto, Japan, has made significant strides in the field of pharmaceuticals with his innovative approach to drug delivery systems. With a focus on sustainable-release compositions, his work has the potential to improve therapeutic outcomes in various medical applications.
Latest Patents: Masanori Fukushima holds a patent for a "Sustained-release pharmaceutical composition." This invention includes a unique combination of a drug, collagen, and at least one type of sugar selected from monosaccharides, disaccharides, trisaccharides, and tetrasaccharides. The composition is noted for its satisfactory handleability and sustained-release properties, which were discovered through the in vivo administration of a collagen solution containing sugar that leads to gelation of the collagen. This innovation is pivotal for controlling the release rate of the drug, making it an effective candidate for sustained-release pharmaceutical applications.
Career Highlights: Throughout his career, Masanori Fukushima has been associated with esteemed institutions, including Kyoto University and Kyoto Prefectural Public University Corporation. His work in these organizations has provided him with a robust platform to develop and patent his innovative pharmaceutical compositions.
Collaborations: In his journey towards innovation, Masanori has collaborated with several notable colleagues, including Hiroaki Matsubara and Satoaki Matoba. Their partnerships have fostered a collaborative environment, enriching the development of sustainable pharmaceutical solutions.
Conclusion: Masanori Fukushima is a remarkable inventor whose contributions to the pharmaceutical industry, particularly in sustained-release compositions, hold promise for future healthcare advancements. As he continues to explore new avenues for innovation, his work is likely to influence drug delivery systems, leading to more efficient and effective therapeutic options for patients.